MDMA enhances emotional empathy and prosocial behavior

Social Cognitive and Affective Neuroscience

Volumn 9, Issue 11, 2014, Pages 1645-1652

  Hysek, Cédric M ^a   Schmid, Yasmin ^a   Simmler, Linda D ^a   Domes, Gregor ^b   Heinrichs, Markus ^b   Eisenegger, Christoph ^c,d   Preller, Katrin H ^e   Quednow, Boris B ^e   Liechti, Matthias E ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY HOSPITAL OF PSYCHIATRY ZURICH   (Switzerland)

Author keywords

Ecstasy; Emotion recognition; Empathy; MDMA; Social behavior; Social cognition

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COPEPTIN; GLYCOPEPTIDE; OXYTOCIN; PSYCHEDELIC AGENT;

ADULT; ANALYSIS OF VARIANCE; BLOOD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EMOTION; EMPATHY; FACE; FEMALE; HUMAN; HUMAN RELATION; MALE; PATTERN RECOGNITION; RANDOMIZED CONTROLLED TRIAL; SOCIAL BEHAVIOR; VISUAL ANALOG SCALE; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EMOTIONS; EMPATHY; FACE; FEMALE; GLYCOPEPTIDES; HALLUCINOGENS; HUMANS; INTERPERSONAL RELATIONS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXYTOCIN; PATTERN RECOGNITION, VISUAL; SOCIAL BEHAVIOR; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84928673482     PISSN: 17495016     EISSN: 17495024     Source Type: Journal    
DOI: 10.1093/scan/nst161     Document Type: Article

References (57)

1. Anderson, I.M., Juhasz, G., Thomas, E., et al. (2011). The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study. European Neuropsychopharmacology, 21, 140-8.
2. Bedi, G., Hyman, D., de Wit, H. (2010). Is ecstasy an "empathogen"? Effects of ± 3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biological Psychiatry, 68, 1134-40.
3. Bedi, G., Phan, K.L., Angstadt, M., de Wit, H. (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology, 207, 73-83.
4. Blair, R.J. (2005). Responding to the emotions of others: dissociating forms of empathy through the study of typical and psychiatric populations. Consciousness and Cognition, 14, 698-718.
5. Brunt, T.M., Koeter, M.W., Niesink, R.J., van den Brink, W. (2012). Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology, 220, 751-62.
6. Crockett, M.J., Clark, L., Hauser, M.D., Robbins, T.W. (2010). Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proceedings of the National Academy of Sciences of the United States of America, 107, 17433-8.
7. Davis, M.H. (1983). Measuring individual differences in empathy: evidence for a multidimensional approach. Journal of Personality and Social Psychology, 44, 113-26.
8. Di Simplicio, M., Massey-Chase, R., Cowen, P.J., Harmer, C.J. (2009). Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. Journal of Psychopharmacology, 23, 241-8.
9. Domes, G., Czieschnek, D., Weidler, F., Berger, C., Fast, K., Herpertz, S.C. (2008). Recognition of facial affect in Borderline Personality Disorder. Journal of Personality Disorders, 22, 135-47.
10. Domes, G., Heinrichs, M., Michel, A., Berger, C., Herpertz, S.C. (2007). Oxytocin improves "mind-reading" in humans. Biological Psychiatry, 61, 731-3.
11. Dumont, G.J., Sweep, F.C., van der Steen, R., et al. (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Social Neuroscience, 4, 359-66.
12. Dziobek, I., Rogers, K., Fleck, S., et al. (2008). Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). Journal of Autism and Developmental Disorders, 38, 464-73.
13. Guastella, A.J., Einfeld, S.L., Gray, K.M., et al. (2010). Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biological Psychiatry, 67, 692-4.
14. Harmer, C.J., Bhagwagar, Z., Perrett, D.I., Vollm, B.A., Cowen, P.J., Goodwin, G.M. (2003a). Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology, 28, 148-52.
15. Harmer, C.J., Hill, S.A., Taylor, M.J., Cowen, P.J., Goodwin, G.M. (2003b). Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. American Journal of Psychiatry, 160, 990-2.
16. Harmer, C.J., Shelley, N.C., Cowen, P.J., Goodwin, G.M. (2004). Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. American Journal of Psychiatry, 161, 1256-63.
17. Harris, D.S., Baggott, M., Mendelson, J.H., Mendelson, J.E., Jones, R.T. (2002). Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology, 162, 396-405.
18. Haruno, M., Frith, C.D. (2010). Activity in the amygdala elicited by unfair divisions predicts social value orientation. Nature Neuroscience, 13, 160-1.
19. Hinkelmann, K., Dragoi, L., Gompf, J., et al. (2010). Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype. Psychiatry Research, 177, 354-7.
20. Hurlemann, R., Patin, A., Onur, O.A., et al. (2010). Oxytocin enhances amygdaladependent, socially reinforced learning and emotional empathy in humans. Journal of Neuroscience, 30, 4999-5007.
21. 2-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics, 340, 286-94.
22. Hysek, C.M., Domes, G., Liechti, M.E. (2012b). MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions. Psychopharmacology, 222, 293-302.
23. Hysek, C.M., Liechti, M.E. (2012). Effects of MDMA alone and after pretreatement with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. Psychopharmacology, 224, 363-76.
24. Hysek, C.M., Schmid, Y., Rickli, A., et al. (2012c). Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. British Journal of Pharmacology, 166, 2277-88.
25. Hysek, C.M., Simmler, L.D., Ineichen, M., et al. (2011). The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clinical Pharmacology and Therapeutics, 90, 246-55.
26. Hysek, C.M., Simmler, L.D., Nicola, V., et al. (2012d). Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study. PLoS One, 7, e36476.
27. Janke, W., Debus, G. (1978). Die Eigenschaftswörterliste. Göttingen: Hogrefe.
28. Kirsch, P., Esslinger, C., Chen, Q., et al. (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience, 25, 11489-93.
29. Knutson, B., Cooper, J.C. (2005). Functional magnetic resonance imaging of reward prediction. Current Opinion in Neurology, 18, 411-7.
30. Knutson, B., Wolkowitz, O.M., Cole, S.W., et al. (1998). Selective alteration of personality and social behavior by serotonergic intervention. American Journal of Psychiatry, 155, 373-9.
31. Kometer, M., Schmidt, A., Bachmann, R., Studerus, E., Seifritz, E., Vollenweider, F.X. (2012). Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Biological Psychiatry, 72, 898-906.
32. Kosfeld, M., Heinrichs, M., Zak, P.J., Fischbacher, U., Fehr, E. (2005). Oxytocin increases trust in humans. Nature, 435, 673-6.
33. Kumsta, R., Heinrichs, M. (2013). Oxytocin, stress and social behavior: neurogenetics of the human oxytocin system. Current Opinion in Neurobiology, 23, 11-6.
34. Liechti, M.E., Gamma, A., Vollenweider, F.X. (2001). Gender differences in the subjective effects of MDMA. Psychopharmacology, 154, 161-8.
35. Marsh, A.A., Yu, H.H., Pine, D.S., Blair, R.J. (2010). Oxytocin improves specific recognition of positive facial expressions. Psychopharmacology, 209, 225-32.
36. Mithoefer, M.C., Wagner, M.T., Mithoefer, A.T., Jerome, I., Doblin, R. (2010). The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology, 25, 439-52.
37. Mithoefer, M.C., Wagner, M.T., Mithoefer, A.T., et al. (2013). Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Journal of Psychopharmacology, 27, 28-39.
38. Morgenthaler, N.G., Struck, J., Alonso, C., Bergmann, A. (2006). Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clinical Chemistry, 52, 112-9.
39. Murphy, R.O., Ackermann, K.A., Handgraaf, M.J.J. (2011). Measuring social value orientation. Judgment Decision Making, 6, 771-81.
40. Neumann, I.D. (2007). Stimuli and consequences of dendritic release of oxytocin within the brain. Biochemical Society Transactions, 35, 1252-7.
41. Neumann, I.D., Maloumby, R., Beiderbeck, D.I., Lukas, M., Landgraf, R. (2013). Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology, 38, 1985-93.
42. Oehen, P., Traber, R., Widmer, V., Schnyder, U. (2013). A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). Journal of Psychopharmacology, 27, 40-52.
43. Ogeil, R.P., Rajaratnam, S.M., Broadbear, J.H. (2013). Male and female ecstasy users: Differences in patterns of use, sleep quality and mental health outcomes. Drug and Alcohol Dependence, 132, 223-30.
44. Paulus, C. (2009). Der Saarbrücker Persönlichkeitsfragebogen SPF (IRI) zur Messung von Empathie: Psychometrische Evaluation der deutschen Version des Interpersonal Reactivity Index. Saarbrücken: Universität des Saarlandes.
45. Pringle, A., McCabe, C., Cowen, P., Harmer, C. (2013). Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline? Journal of Psychopharmacology, 27, 719-31.
46. Reneman, L., Booij, J., de Bruin, K., et al. (2001). Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet, 358, 1864-9.
47. Rosenson, J., Smollin, C., Sporer, K.A., Blanc, P., Olson, K.R. (2007). Patterns of ecstasyassociated hyponatremia in California. Annals of Emergency Medicine, 49, 164-71.
48. Simmler, L.D., Hysek, C.M., Liechti, M.E. (2011). Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. Journal of Clinical Endocrinology and Metabolism, 96, 2844-50.
49. Smeets, T., Dziobek, I., Wolf, O.T. (2009). Social cognition under stress: differential effects of stress-induced cortisol elevations in healthy young men and women. Hormones and Behavior, 55, 507-13.
50. Smith, A.L., Freeman, S.M., Stehouwer, J.S., et al. (2012). Synthesis and evaluation of C-11, F-18 and I-125 small molecule radioligands for detecting oxytocin receptors. Bioorganic and Medicinal Chemistry, 20, 2721-38.
51. Stevens, J.S., Hamann, S. (2012). Sex differences in brain activation to emotional stimuli: a meta-analysis of neuroimaging studies. Neuropsychologia, 50, 1578-93.
52. Thompson, M.R., Callaghan, P.D., Hunt, G.E., Cornish, J.L., McGregor, I.S. (2007). A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy"). Neuroscience, 146, 509-14.
53. Thompson, R.R., George, K., Walton, J.C., Orr, S.P., Benson, J. (2006). Sex-specific influences of vasopressin on human social communication. Proceedings of the National Academy of Sciences of the United States of America, 103, 7889-94.
54. van Dijken, G.D., Blom, R.E., Hene, R.J., Boer, W.H. (2013). High incidence of mild hyponatraemia in females using ecstasy at a rave party. Nephrology Dialysis Transplantation, 28, 277-83.
55. Wood, R.M., Rilling, J.K., Sanfey, A.G., Bhagwagar, Z., Rogers, R.D. (2006). Effects of tryptophan depletion on the performance of an iterated Prisoner's Dilemma game in healthy adults. Neuropsychopharmacology, 31, 1075-84.
56. Zak, P.J., Stanton, A.A., Ahmadi, S. (2007). Oxytocin increases generosity in humans. PLoS One, 2, e1128.
57. Zald, D.H. (2003). The human amygdala and the emotional evaluation of sensory stimuli. Brain Research, 41, 88-123.